BSGM Stock Summary and Trading Ideas (Biosig Technologies | NASDAQ:BSGM)

BioSig Technologies Inc is a commercial stage medical device company. It is developing a proprietary technology platform to minimize noise and artifacts from cardiac recordings during electrophysiology studies and ablation.

Biosig Technologies trades on the NASDAQ stock market under the symbol BSGM.

As of April 18, 2024, BSGM stock price declined to $1.54 with 393,093 million shares trading.

BSGM has a beta of -1.35, meaning it tends to be less sensitive to market movements. BSGM has a correlation of 0.01 to the broad based SPY ETF.

BSGM has a market cap of $17.25 million. This is considered a Sub-Micro Cap stock.

Last quarter Biosig Technologies reported $1,000 in Revenue and -$.60 earnings per share. This fell short of revenue expectation by $-79,000 and exceeded earnings estimates by $.30.

In the last 3 years, BSGM stock traded as high as $45.80 and as low as $.26.

The top ETF exchange traded funds that BSGM belongs to (by Net Assets): VXF, IWC.

BSGM has underperformed the market in the last year with a return of -87.4%, while the SPY ETF gained +22.3%. In the last 3 month period, BSGM fell short of the market, returning -46.5%, while SPY returned +6.1%. However, in the most recent 2 weeks BSGM has outperformed the stock market by returning +137.3%, while SPY returned -3.8%.

BSGM support price is $1.34 and resistance is $1.92 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BSGM stock will trade within this expected range on the day.